Key facts
- It has raised $2.0M; the latest was Later Stage VC ($1.3M) in Jun 2025.
- Notable investors include Mirai Souzou Investments, Vision Incubate.
- Status: Privately Held (no backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for AMS Planning
- ·The full record, as it builds
Funding rounds
No funding rounds for AMS Planning are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About AMS Planning
Developer of nuclear medicine technologies designed to transform Japan's healthcare infrastructure by advancing clinical innovation and operational efficiency. The company's technologies offer next-generation diagnostics, novel radiotherapeutics, and proprietary radioactive waste management systems, enabling hospitals and healthcare providers in Japan to expand access to precision oncology, accelerate patient throughput, and comply with regulations while scaling nuclear medicine treatments nationwide.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2019
- Website
- ams-plan.com/
- Ownership
- Privately Held (no backing)
AMS Planning doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AMS Planning shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AMS Planning in its N-PORT filings yet. We sweep new filings monthly.